TP53 Status and Estrogen Receptor-beta in Triple Negative Breast Cancer: Company matters

Simple item page
dc.contributor.authorBadve, Sunil
dc.contributor.authorGokmen-Polar, Yesim
dc.contributor.departmentPathology and Laboratory Medicine, School of Medicineen_US
dc.date.accessioned2019-05-23T19:39:02Z
dc.date.available2019-05-23T19:39:02Z
dc.date.issued2019
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationBadve, S., & Gokmen-Polar, Y. (2019). TP53 Status and Estrogen Receptor-beta in Triple Negative Breast Cancer: Company matters. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djz052en_US
dc.identifier.urihttps://hdl.handle.net/1805/19456
dc.language.isoenen_US
dc.publisherOxforden_US
dc.relation.isversionof10.1093/jnci/djz052en_US
dc.relation.journalJNCI: Journal of the National Cancer Instituteen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjecttriple-negative breast cancersen_US
dc.subjectTP53 statusen_US
dc.subjectestrogen receptor-betaen_US
dc.titleTP53 Status and Estrogen Receptor-beta in Triple Negative Breast Cancer: Company mattersen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Badve_2019_TP53.pdf
Size:
294.97 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Pathology and Laboratory Medicine Works
Sunil Badve